AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11473839
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (2 to 3 mg morphine epidurally, followed by infusion at a rate of 0.2 mg/h)
Trial: 9892913
Drug: Oral terbinafine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terbinafine 250 mg once daily for 1 week
Trial: 9892913
Drug: 1% clotrimazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% clotrimazole cream applied twice daily for 4 weeks
Trial: 3291529
Drug: CQP 201‐403
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQP 201‐403 at 0.005 mg daily
Trial: 3291529
Drug: CQP 201‐403
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQP 201‐403 at 0.015 mg daily
Trial: 3291529
Drug: CQP 201‐403
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQP 201‐403 at 0.025 mg daily
Trial: 1711753
Drug: Intralesional injection
RxNorm normalized name: DEXAMETHASONE SODIUM PHOSPHATE 4 mg in 1 mL INTRALESIONAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional injection of bleomycin sulphate (1 unit/ml)
Trial: 28965748
Drug: Pharmacist case
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist case finding and intervention program (Medication Therapy Management consultation, patient assessment, laboratory assessment, individualized CV risk assessment)
Trial: 15142088
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with immediate implant and subepithelial connective tissue graft (test group)
Trial: 15142088
Drug: Single immediate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single immediate implants (control group)
Trial: 9882085
Drug: Dexketoprofen trometamol
RxNorm normalized name: Dexketoprofen trometamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen trometamol 25 mg tid
Trial: 9882085
Drug: Ketoprofen 50
RxNorm normalized name: ketoprofen 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 50 mg tid
Trial: 8049819
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg terbutaline
Trial: 2893778
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg terbutaline
Trial: 1813613
Drug: Desipramine (tricyclic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desipramine (tricyclic antidepressant)
Trial: 2500111
Drug: Fluvoxamine (5-HT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (5-HT reuptake inhibitor)
Trial: 26939522
Drug: Cer‐Mg and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cer‐Mg and hydrocortisone
Trial: 26939522
Drug: Cer‐Mg and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cer‐Mg and emollient
Trial: 26939522
Drug: Cer‐Mg cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cer‐Mg cream
Trial: 23136274
Drug: Diagnostic and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diagnostic and treatment package for malaria and pneumonia using rapid diagnostic tests (RDT)
Trial: 23136274
Drug: Presumptive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presumptive treatment with anti-malarial drugs; artemisinin combination therapy (ACT)
Trial: 15302228
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg beta‐methyl‐6‐chloromelatonin
Trial: 15302228
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg beta‐methyl‐6‐chloromelatonin
Trial: 15302228
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg beta‐methyl‐6‐chloromelatonin
Trial: 1353678
Drug: Vecuronium (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (0.5 mg bolus i.v. followed by 0.5 mg infused over 30 min)
Trial: 25407798
Drug: Aleglitazar 150
RxNorm normalized name: Aleglitazar
DrugBank: Aleglitazar (DB08915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aleglitazar 150 μg/day
Trial: 21995889
Drug: Life review
RxNorm normalized name: Life-O-Gen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Life review therapy
Trial: 22420349
Drug: Placebo condition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo condition with supportive therapy
Trial: 17563512
Drug: Immediate loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate loading of mandibular bar-retained overdenture supported by 4 endosseous implants loaded immediately after implant placement.
Trial: 17563512
Drug: Delayed loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed loading of mandibular bar-retained overdenture supported by 4 endosseous implants that remained submerged for a period of 4 months before loading.
Trial: 12182268
Drug: Cue exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cue exposure following a priming dose
Trial: 15753142
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplements
Trial: 7015820
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplements
Trial: 2182978
Drug: Active management
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active management with i.v. Ergometrine 0.5 mg
Trial: 15377842
Drug: Intravenous clodronate
RxNorm normalized name: Clodronic acid
DrugBank: Clodronic acid (DB00720)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous clodronate (1500 mg each, seven cycles)
Trial: 11429351
Drug: Morphine 1
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 1 mg/mL plus ketamine 1 mg/mL (Group MK)
Trial: 11429351
Drug: Morphine 1
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 1 mg/mL (Group M)
Trial: 9701181
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (375 mL/d)
Trial: 9701181
Drug: RWPP capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RWPP capsules (1 g/d)
Trial: 9701181
Drug: RWPPs in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RWPPs in white wine (1 g/d)
Trial: 9701181
Drug: White wine
RxNorm normalized name: White wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White wine (375 mL/d)
Trial: 9701181
Drug: Control alcoholic
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control alcoholic drink (40 g ethanol/d)
Trial: 9701181
Drug: RWPPs (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RWPPs (1 g/d)
Trial: 9701181
Drug: RWPPs (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RWPPs (2 g/d)
Trial: 9390335
Drug: Tacalcitol ointment
RxNorm normalized name: tacalcitol
DrugBank: Tacalcitol (DB13689)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacalcitol ointment (4 micrograms/g) once daily
Trial: 9390335
Drug: Calcipotriol ointment
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol ointment (50 micrograms/g) twice daily
Trial: 1759492
Drug: Acellular pertussis
RxNorm normalized name: Acellular pertussis vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular pertussis vaccine (PT‐9K/129G, FHA, 69 kDa)
Trial: 7117678
Drug: Nabumetone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabumetone (1 g at night) for 2 weeks
Trial: 7117678
Drug: Naproxen (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (250 mg b.i.d) for 2 weeks
Trial: 7117678
Drug: Drug preference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug preference
Trial: 31605520
Drug: Caffeine tablet
RxNorm normalized name: Caffeine Tablets
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine tablet (CT)
Trial: 15462108
Drug: Irbesartan (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan (150 mg once daily)
Trial: 15462108
Drug: Fosinopril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosinopril (20 mg once daily)
Trial: 3943269
Drug: Nalmefene 2
RxNorm normalized name: nalmefene 27 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalmefene 2 mg
Trial: 3946804
Drug: Nalmefene 1
RxNorm normalized name: nalmefene 1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalmefene 1 mg
Trial: 3946804
Drug: Nalmefene 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalmefene 0.5 mg
Trial: 27085566
Drug: Oximacro (36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oximacro (36 mg PACs‐A) administered twice per day for 7 days
Trial: 27085566
Drug: Oximacro (36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oximacro (36 mg PACs‐A)
Trial: 24399428
Drug: Sertraline plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline plus clonazepam (up to 3.0 mg/day)
Trial: 24399428
Drug: Venlafaxine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (up to 225 mg/day)
Trial: 18417963
Drug: Danqi Piantan
RxNorm normalized name: Yellow fever virus 17D/tiantan live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danqi Piantan Jiaonang (DPJ) 4 capsules (0.4 g/capsule) taken orally 2 times 6 hours apart
Trial: 18417963
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of aspirin 300 mg and 2 doses of DPJ 4 capsules taken 6 hours apart
Trial: 18417963
Drug: Danqi Piantan
RxNorm normalized name: Yellow fever virus 17D/tiantan live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danqi Piantan Jiaonang (DPJ) 4 capsules taken orally 3 times a day for 1 month
Trial: 15783004
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no herbal medicine)
Trial: 30167807
Drug: Intensive systolic
RxNorm normalized name: Bystolic
DrugBank: Nebivolol (DB04861)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive systolic blood pressure treatment (< 120 mmHg) in the low-SBP group
Trial: 30167807
Drug: Standard systolic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard systolic blood pressure treatment (< 140 mmHg) in the low-SBP group
Trial: 30167807
Drug: Intensive systolic
RxNorm normalized name: Bystolic
DrugBank: Nebivolol (DB04861)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive systolic blood pressure treatment (< 120 mmHg) in the high-SBP group
Trial: 30167807
Drug: Standard systolic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard systolic blood pressure treatment (< 140 mmHg) in the high-SBP group
Trial: 20816187
Drug: Combination inhaler
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination inhaler (125 microg fluticasone dipropionate and 25 microg salmeterol, 2 actuations twice daily)
Trial: 20816187
Drug: Separate inhalers
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate inhalers (125 microg fluticasone dipropionate and 25 microg salmeterol, 2 actuations twice daily)
Trial: 20816187
Drug: Combination inhaler
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination inhaler vs. fluticasone
Trial: 20816187
Drug: Combination inhaler
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination inhaler vs. salmeterol
Trial: 18077927
Drug: Paroxetine oral
RxNorm normalized name: paroxetine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine oral solution (20 mg/20 drops)
Trial: 18077927
Drug: Paroxetine tablets
RxNorm normalized name: Paroxetine Tablets
DrugBank: Paroxetine (DB00715)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paroxetine tablets (20 mg)
Trial: 9796960
Drug: Intravenous mesna
RxNorm normalized name: Mesna
DrugBank: Coenzyme M (DB09110)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous mesna
Trial: 9796960
Drug: Oral mesna
RxNorm normalized name: Mesna
DrugBank: Coenzyme M (DB09110)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral mesna
Trial: 9796960
Drug: Both i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both i.v. and oral mesna
Trial: 2650897
Drug: 15 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg.kg‐1 rectal methohexitone
Trial: 2650897
Drug: 20 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg.kg‐1 rectal methohexitone
Trial: 2650897
Drug: 25 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg.kg‐1 rectal methohexitone
Trial: 2650897
Drug: 30 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg.kg‐1 rectal methohexitone
Trial: 2650897
Drug: 15 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg.kg‐1 and 20 mg.kg‐1 rectal methohexitone
Trial: 1096630
Drug: 1% tetracycline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% tetracycline ointment
Trial: 1096630
Drug: 1% rifampicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% rifampicin ointment
Trial: 1096630
Drug: 5% boric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% boric acid ointment
Trial: 31248663
Drug: Drug-coated balloon
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-coated balloon
Trial: 19751560
Drug: Low-dose hydrocortisone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose hydrocortisone
Trial: 18547287
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone for 2 weeks and intranasal budesonide for 12 weeks (treatment group)
Trial: 16299871
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment for 1 year after 2 years of treatment)
Trial: 14658
Drug: Lorazepam (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (4 mg)
Trial: 12006794
Drug: Flumazenil (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (0.5 mg) administered to seven benzodiazepine-treated patients
Trial: 7473011
Drug: Tetracycline HCl
RxNorm normalized name: tetracycline HCl
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracycline HCl (TTC) 10 mg/ml for 1 minute
Trial: 7473011
Drug: Tetracycline HCl
RxNorm normalized name: tetracycline HCl
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracycline HCl (TTC) 10 mg/ml for 4 minutes
Trial: 7473011
Drug: Tetracycline HCl
RxNorm normalized name: tetracycline HCl
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracycline HCl (TTC) 100 mg/ml for 1 minute
Trial: 7473011
Drug: Tetracycline HCl
RxNorm normalized name: tetracycline HCl
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracycline HCl (TTC) 100 mg/ml for 4 minutes
Trial: 6161804
Drug: Oral prophylaxis
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prophylaxis with broad spectrum tetracycline (Group B)
Trial: 6161804
Drug: Infusion prophylaxis
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Infusion prophylaxis (Group C)
Trial: 25294223
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Group A)
Trial: 27416975
Drug: Bacillus Calmette-Guérin
RxNorm normalized name: Bacillus Calmette-Guérin (BCG) vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus Calmette-Guérin maintenance therapy (intravesical instillations once a week for 3 weeks at 3, 6, 12 and 18 months after induction)
Trial: 27416975
Drug: Non-maintenance group
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-maintenance group (bacillus Calmette-Guérin induction therapy only)
Trial: 27416975
Drug: Bacillus Calmette-Guérin
RxNorm normalized name: Bacillus Calmette-Guérin (BCG) vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus Calmette-Guérin maintenance therapy
Trial: 25661190
Drug: Intranasal fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal fluticasone furoate
Trial: 19875277
Drug: Transdermal tulobuterol
RxNorm normalized name: tulobuterol
DrugBank: Tulobuterol (DB12248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal tulobuterol (2mg) combined with inhaled tiotropium (18microg)
Trial: 19875277
Drug: Inhaled tiotropium
RxNorm normalized name: tiotropium Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled tiotropium (18microg)
Trial: 18412932
Drug: MXR 1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MXR 1500 mg once daily after dinner
Trial: 18412932
Drug: MIR 500
RxNorm normalized name: Dextran-coated, nanoparticle-conjugated stabilized synthetic antisense oligonucleotide targeting miR-10b
DrugBank: TTX-MC138 (DB18628)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MIR 500 mg thrice daily after meals
Trial: 16319559
Drug: Therapist‐administered programme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapist‐administered programme
Trial: 12566477
Drug: Selenium supplement
RxNorm normalized name: Selenium supplement
DrugBank: Selenious acid (DB11127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplement (200 micro g) for 20 weeks
Trial: 1721787
Drug: Combined drug
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined drug (quinine/quinidine/cinchonine) high dose regimen
Trial: 1721787
Drug: Combined drug
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined drug (quinine/quinidine/cinchonine) low dose regimen
Trial: 6416399
Drug: Rectal indomethacin
RxNorm normalized name: indomethacin Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal indomethacin 100 mg administered eight hourly
Trial: 6416399
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of rectal indomethacin and cryoanalgesia
Trial: 6416399
Drug: Conventional intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional intramuscular opiate analgesia
Trial: 22829919
Drug: Monthly sulfadoxine-pyrimethamine
RxNorm normalized name: pyrimethamine / sulfadoxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly sulfadoxine-pyrimethamine and two doses of azithromycin (AZI-SP)
Trial: 31063503
Drug: Control (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (two doses of sulfadoxine-pyrimethamine)
Trial: 26458336
Drug: Cilostazol treatment
RxNorm normalized name: Cilostazol
DrugBank: Cilostazol (DB01166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cilostazol treatment after 90 days
Trial: 25073942
Drug: Decompression with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decompression with Wallis implant
Trial: 21785897
Drug: 15 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g/kg of charcoal-barbecued meat (experiment 1)
Trial: 21785897
Drug: 30 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g/kg of charcoal-barbecued meat (experiment 2)
Trial: 19735233
Drug: Dexlansoprazole MR
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole MR (all doses)
Trial: 15843763
Drug: Stimulant +
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant + fluvoxamine (STIM/FLV)
Trial: 15843763
Drug: Stimulant +
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant + placebo (STIM/PL)
Trial: 2254498
Drug: Hypnotic induction
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic induction at the beginning of each session
Trial: 7001491
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg proquazone per day
Trial: 7001491
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg proquazone per day
Trial: 25675721
Drug: Meldonium 1000
RxNorm normalized name: meldonium
DrugBank: Meldonium (DB13723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meldonium 1000 mg/day for 3 months during winter
Trial: 19422623
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of paroxetine
Trial: 8021700
Drug: Hydroquinine hydrobromide
RxNorm normalized name: hydroquinine
DrugBank: Hydroquinine (DB13718)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroquinine hydrobromide (300 mg/day)
Trial: 2605070
Drug: i.v. omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. omeprazole 40 mg 1 h before surgery
Trial: 2605070
Drug: i.v. omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. omeprazole 40 mg 3 h before surgery
Trial: 163625
Drug: Intensive psychosocial
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive psychosocial inhospital treatment (mean length of stay 30 days)
Trial: 27161546
Drug: Fimasartan 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fimasartan 120 mg
Trial: 30882901
Drug: Localized index
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Localized index node removal after neoadjuvant immunotherapy